Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α

[1]  Yen-Ching Chen,et al.  Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α , 2012, Journal of Neuroinflammation.

[2]  V. Marzo,et al.  Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide , 2011, Journal of cellular and molecular medicine.

[3]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[4]  M. O’Banion,et al.  Neuroinflammatory processes in Alzheimer’s disease , 2010, Journal of Neural Transmission.

[5]  H. Hansen.  Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain , 2010, Experimental Neurology.

[6]  Fred H. Gage,et al.  Mechanisms Underlying Inflammation in Neurodegeneration , 2010, Cell.

[7]  S. Cuzzocrea,et al.  Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation , 2009, Proceedings of the National Academy of Sciences.

[8]  V. Marzo,et al.  Anti‐inflammatory Effect of Palmitoylethanolamide on Human Adipocytes , 2009, Obesity.

[9]  K. Fuxe,et al.  Neurotensin receptor involvement in the rise of extracellular glutamate levels and apoptotic nerve cell death in primary cortical cultures after oxygen and glucose deprivation. , 2008, Cerebral cortex.

[10]  J. Bright,et al.  PPAR Regulation of Inflammatory Signaling in CNS Diseases , 2008, PPAR research.

[11]  E. Mazzon,et al.  Effects of Palmitoylethanolamide on Signaling Pathways Implicated in the Development of Spinal Cord Injury , 2008, Journal of Pharmacology and Experimental Therapeutics.

[12]  N. Stella,et al.  Microglia produce and hydrolyze palmitoylethanolamide , 2008, Neuropharmacology.

[13]  G. Landreth,et al.  PPARs in the brain. , 2007, Biochimica et biophysica acta.

[14]  G. Landreth.  Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease. , 2007, Current Alzheimer research.

[15]  G. Landreth.  Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease. , 2007, Current Alzheimer research.

[16]  Tony Wyss-Coray,et al.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.

[17]  Roberto Russo,et al.  The search for the palmitoylethanolamide receptor. , 2005, Life sciences.

[18]  M. Block,et al.  Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism , 2005, Progress in Neurobiology.

[19]  D. Piomelli,et al.  The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide , 2005, Molecular Pharmacology.

[20]  D. Greenberg,et al.  Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility , 2003, The Journal of Neuroscience.

[21]  G. Scambia,et al.  Erythropoietin exerts anti‐apoptotic effects on rat microglial cells in vitro , 2002, The European journal of neuroscience.

[22]  T. Möller,et al.  Astrocytes in Culture Produce Anandamide and Other Acylethanolamides* , 2002, The Journal of Biological Chemistry.

[23]  R. Mrak,et al.  Interleukin-1, neuroinflammation, and Alzheimer’s disease , 2001, Neurobiology of Aging.

[24]  H. Hansen,et al.  N-Acylethanolamines and precursor phospholipids - relation to cell injury. , 2000, Chemistry and physics of lipids.

[25]  E. Meli,et al.  1‐Aminoindan‐1,5‐dicarboxylic acid and (S)‐(+)‐2‐(3′‐carboxybicyclo[1.1.1] pentyl)‐glycine, two mGlu1 receptor‐preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia , 1999, The European journal of neuroscience.

[26]  T. Willson,et al.  Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.

[27]  A. Buriani,et al.  The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Umesono,et al.  Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors , 1992, Nature.